Trushar R Patel

Dr. Trushar R Patel

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2016 in Biophysical Reviews
Verified
Journal Article
Closed access
PDF file
JSJörg Stetefeld
Jörg Stetefeld
SMSean McKenna
Sean McKenna
TPTrushar R Patel
Trushar R Patel

14 October 2020 in World Journal of Gastroenterology
Verified
Journal Article
Closed access
SDSimmone D'Souza
Simmone D'Souza
KLKeith Ck Lau
Keith Ck Lau
CCCarla S Coffin
Carla S Coffin
TPTrushar R Patel
Trushar R Patel
Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. Solid tumors like HCC are complex and have heterogeneous tumor genomic profiles contributing to complexity in diagnosis and management. Chronic infection with hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) are the greatest etiological risk factors for HCC. Due to the significant role of chronic viral infection in HCC development, it is important to investigate direct (viral associated) and indirect (immune-associated) mechanisms involved in the pathogenesis of HCC. Common mechanisms used by HBV, HCV, and HDV that drive hepatocarcinogenesis include persistent liver inflammation with an impaired antiviral immune response, immune and viral protein-mediated oxidative stress, and deregulation of cellular signaling pathways by viral proteins. DNA integration to promote genome instability is a feature of HBV infection, and metabolic reprogramming leading to steatosis is driven by HCV infection. The current review aims to provide a brief overview of HBV, HCV and HDV molecular biology, and highlight specific viral-associated oncogenic mechanisms and common molecular pathways deregulated in HCC, and current as well as emerging treatments for HCC.

1 February 2016 in Cancer Cell
Verified
Journal Article
Closed access
MGMélodie Grandin
Mélodie Grandin
MMMarkus Meier
Markus Meier
JDJean Guy Delcros
Jean Guy Delcros
DNDenise Nikodemus
Denise Nikodemus
RRRaphael Reuten
Raphael Reuten
JSJörg Stetefeld
Jörg Stetefeld

30 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
RARodrigo Aguilar
Rodrigo Aguilar
KSKerrie B. Spencer
Kerrie B. Spencer
BKBarry Kesner
Barry Kesner
NRNoreen F. Rizvi
Noreen F. Rizvi
MBMaulik D. Badmalia
Maulik D. Badmalia
JLJeannie T. Lee
Jeannie T. Lee

1 July 2009 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MMMarkus Meier
Markus Meier
GPG. Pauline Padilla
G. Pauline Padilla
HHHarald Herrmann
Harald Herrmann
TWTatjana Wedig
Tatjana Wedig
MHMichaela Hergt
Michaela Hergt
PBPeter Burkhard
Peter Burkhard

30 November 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
RRRaphael Reuten
Raphael Reuten
TPTrushar R Patel
Trushar R Patel
MMMatthew McDougall
Matthew McDougall
NRNicolas Rama
Nicolas Rama
DNDenise Nikodemus
Denise Nikodemus
MKManuel Koch
Manuel Koch
Netrins, a family of laminin-related molecules, have been proposed to act as guidance cues either during nervous system development or the establishment of the vascular system. This was clearly demonstrated for netrin-1 via its interaction with the receptors DCC and UNC5s. However, mainly based on shared homologies with netrin-1, netrin-4 was also proposed to play a role in neuronal outgrowth and developmental/pathological angiogenesis via interactions with netrin-1 receptors. Here, we present the high-resolution structure of netrin-4, which shows unique features in comparison with netrin-1, and show that it does not bind directly to any of the known netrin-1 receptors. We show that netrin-4 disrupts laminin networks and basement membranes (BMs) through high-affinity binding to the laminin γ1 chain. We hypothesize that this laminin-related function is essential for the previously described effects on axon growth promotion and angiogenesis. Our study unveils netrin-4 as a non-enzymatic extracellular matrix protein actively disrupting pre-existing BMs.